» Articles » PMID: 34946511

Insight into OroxylinA-7--β-d-Glucuronide-Enriched Bark Extract in Oral Cancer HSC-3 Cell Apoptotic Mechanism: Role of Mitochondrial Microenvironment

Abstract

, of the Bignoniaceae family, has various ethnomedical uses such as an astringent, anti-inflammatory, anti-bronchitis, anti-helminthic and anti-microbial, including anticancer properties. The druggability of OI stem bark extract was determined by its molecular docking interactions with PARP and Caspase-3, two proteins involved in cell survival and death. Note that 50 µg/mL of extract (OIE) showed a significant ( < 0.05%) toxicity to HSC-3 cells. MTT aided cell viability and proliferation assay demonstrated that 50 µg/mL of OIE displayed significant ( < 0.5%) reduction in cell number at 4 h of incubation time. Cell elongation and spindle formation was noticed when HSC-3 cells were treated with 50 µg/mL of OIE. OIE initiated DNA breakage and apoptosis in HSC-3 cells, as evident from DNA ladder assay and calcein/EB staining. Apoptosis potential of OIE is confirmed by flow cytometer and triple-staining (live cell/apoptosis/necrosis) assay. Caspase-3/7 fluorescence quenching (LANCE) assay demonstrated that 50 µg/mL of OIE significantly enhanced the RFU of caspases-3/7, indicating that the apoptosis potential of OIE is probably through the activation of caspases. Immuno-cytochemistry of HSC-3 cells treated with 50 µg/mL of OIE showed a significant reduction in mitochondrial bodies as well as a reduction in RFU in 60 min of incubation time. Immunoblotting studies clearly showed that treatment of HSC-3 cells with OI extract caused caspase-3 activation and PARP deactivation, resulting in apoptotic cell death. Overall, our data indicate that OIE is an effective apoptotic agent for human squamous carcinoma cells and it could be a future cancer chemotherapeutic target.

Citing Articles

Anticancer potential of phytochemicals from targeting Lactate Dehydrogenase A through bioinformatic approach.

Ahmed S, Rahman M, Alqahtani A, Sultana N, Almarfadi O, Ali M Toxicol Rep. 2022; 10:56-75.

PMID: 36583135 PMC: 9792705. DOI: 10.1016/j.toxrep.2022.12.007.


Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide.

Maszczyk M, Banach K, Karkoszka M, Rzepka Z, Rok J, Beberok A Int J Mol Sci. 2022; 23(10).

PMID: 35628432 PMC: 9144651. DOI: 10.3390/ijms23105621.

References
1.
Gogvadze V, Orrenius S, Zhivotovsky B . Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol. 2008; 19(1):57-66. DOI: 10.1016/j.semcancer.2008.11.007. View

2.
Hengartner M . The biochemistry of apoptosis. Nature. 2000; 407(6805):770-6. DOI: 10.1038/35037710. View

3.
Bouchier-Hayes L, Lartigue L, Newmeyer D . Mitochondria: pharmacological manipulation of cell death. J Clin Invest. 2005; 115(10):2640-7. PMC: 1236694. DOI: 10.1172/JCI26274. View

4.
Gulbins E, Dreschers S, Bock J . Role of mitochondria in apoptosis. Exp Physiol. 2003; 88(1):85-90. DOI: 10.1113/eph8802503. View

5.
Modica-Napolitano J, Singh K . Mitochondrial dysfunction in cancer. Mitochondrion. 2005; 4(5-6):755-62. DOI: 10.1016/j.mito.2004.07.027. View